Brewers outfielder Ryan Braun had his 50-game performance-enhancing drug suspension overturned Thursday after independent arbitrator Shyam Das ruled that there were legitimate chain of custody issues with the urine sample that eventually tested positive for elevated levels of synthetic testosterone.
After a thorough review of the joint drug agreement between Major League Baseball and its Players Association — a document that is conveniently available in PDF form on MLB.com — I’m not so sure that Das came to the right conclusion.
Braun’s argument during his January appeal in New York City was that the courier who collected his urine made a number of against-protocol moves after leaving the testing area. But were mistakes really made?
- The courier did not immediately head to a FedEx Office after collecting Braun’s sample following an early-October game because it was late on a Saturday night and he figured the store would be closed. Braun (or, rather, his lawyers) argued in January that the courier’s action was against policy, but the MLB-MLBPA joint drug agreement states that “specimens cannot be placed in a FedEx Drop Box” and the five FedEx Office locations closest to Miller Park are all closed before 9 p.m. on Saturdays. In fact, the location closest to Miller Park — just 3.28 miles away — isn’t open at all on Saturdays.
- Also, none of the FedEx Office locations in the Milwaukee area ship items out on Sundays. So instead of giving the sealed cup of urine to a FedEx Office employee at some point Sunday and hoping for proper handling, the courier followed the terms of the MLB-MLBPA joint drug agreement (see pages 37-39) by storing Braun’s urine sample in a secure refrigerator at his residence until Monday morning, when FedEx could finally get the shipment to the appropriate testing lab in Montreal.
- The MLB-MLBPA joint drug agreement fully allows for temporary storage by couriers — people who are trained and paid to handle drug test samples, and do so as a profession — as long as the specimen can be “appropriately safeguarded,” kept in a “cool and secure location,” with “chain of custody intact.” A refrigerator in the private residence of a trained doping officer would seem to fit those guidelines.
So if the courier is allowed to temporarily store samples on his own, and he did so in his own residence, where exactly is the chain of custody issue? And why did Das rule to have the suspension overturned?
Furthermore, consider this series of tweets from Jeff Passan of Yahoo! Sports:
Passan also notes in his latest column that the courier testified in person at Braun’s January appeal hearing in Manhattan and assured those present that the urine sample was packaged into two tamper-resistant containers with security seals. Both seals were unbroken upon their arrival at the testing lab in Montreal.
CC Sabatha made headlines in October when he abruptly left the Yankees to go into alcohol rehab. After a month there he came back and gave interviews about his decision and his battle with the bottle and then disappeared into the offseason the way most players do.
He emerged the other day and spoke with the New York Daily News’ Mark Feinsand and says that he’s ready for baseball once again. Indeed, in some ways he’s more ready now than he usually is by mid February. He’s been throwing bullpen sessions for the past three weeks — he normally waits until he gets to Tamps — and he says his troublesome knee is feeling good.
Sabathia will turn 36 during the season. In 2015 he was 6-10 with a 4.73 ERA in 29 starts and posted his lowest strikeout rate in a decade. Late in the season, however, with the help of a knee brace, he was at his most effective in some time. He won’t need to return to 2008 form in order to help the Yankees this season, but he will need to look more like he did in September if he is to help the Yankees to the playoffs.
The Mets are currently enjoying the spoils of the best young rotation in the game, but the big question is whether this is just a brief window or the start of sustained success. Given the huge prices on the free agent market, it’s going to be next to impossible to keep the band together, but at least one member of the rotation is open to sticking around for the long-term.
While there haven’t been any talks yet, All-Star right-hander Jacob deGrom told Kevin Kernan of the New York Post that he could see himself discussing an extension with the Mets.
“I’m a little bit older, so I might be more willing to do something like that,’’ deGrom told The Post at Mets pre-camp. “You just have to look at what is fair so both sides get a decent deal. It’s something I’d have to look into and make sure I agree with it.’’
It makes sense from deGrom’s perspective. He broke into the majors later than most prospects, so he’ll be 28 this June. Depending on whether he qualifies as a Super Two, he’ll be arbitration-eligible for the first time after either 2016 or 2017. Either way, he’s under team control through 2020, which means that he’s currently on track to hit free agency after his age-32 season. The market might not be kind to him even if he manages to stay healthy, so it could behoove him to get as much guaranteed money as possible right now. The Mets could always decide to play things year-to-year, but perhaps deGrom would be willing to settle for a discount in order to get them to buy out a free agent year or two. It’s a really interesting situation to think about, but odds are the two sides will wait on contract talks until he’s arbitration-eligible for the first time.
DeGrom owns a 2.61 ERA in 52 starts over his first two seasons in the majors. Among starters, only Zack Greinke, Jake Arrieta, and Clayton Kershaw have a lower ERA since the start of 2014.
The Royals and third baseman Mike Moustakas have avoided arbitration by agreeing to a two-year, $14.3 million deal, reports Jon Heyman of MLB Network.
The deal, which was initially discussed last month, buys out Moustakas’ final two years of arbitration. Jeffrey Flanagan of MLB.com reports that it’s believed he’ll make $5.6 million in 2016 and $8.7 million in 2017.
The 27-year-old Moustakas posted an underwhelming .668 OPS over his first four seasons in the majors, but he enjoyed a big postseason in 2014 before breaking out last season by batting .284/.348/.470 with 22 home runs and 82 RBI.
ESPN’s Jerry Crasnick reported this morning that free agent reliever Tommy Hunter required core muscle repair surgery earlier this offseason. Coming off a disappointing 2015, it’s understandable why he’s still on the market, but it sounds like he has at least one significant lead.
Marc Topkin of the Tampa Bay Times hears that the Rays are having “advanced talks” with Hunter as they attempt to add an experienced arm to their bullpen. Nothing is considered close and Hunter is also talking to other clubs. Meanwhile, the Rays have been in touch with veteran reliever Ryan Webb while monitoring the trade market.
Hunter posted a 2.88 ERA as a late-inning arm from 2013-2014, but he compiled a mediocre 4.18 ERA over 58 appearances last season between the Orioles and Cubs. On the bright side, his velocity has held steady and his control is still very good. Despite the down year and core muscle surgery, Topkin writes that Hunter may be holding out for a multi-year deal.